- Lobbying
- Lobbying by Lehigh Valley Technologies
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Dan Moll | Dep. Staff Dir; House Gov. Reform Cmte; 97-03 |
Larry Flick | n/a |
Allison King | n/a |
Liz Brinkerhoff | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Termination
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Drug Enforcement Administration (DEA)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Drug Enforcement Administration (DEA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues relating to access and availability of generic and branded-generic pharmaceuticals. Issues relating to DEA..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate